NL-OMON37782
Completed
N/A
Safeguarding the brain of our smallest children ;* an investigator-initiated randomised, blinded, multinational, phase II feasibility clinical trial on near-infrared spectroscopy monitoring combined with defined treatment guidelines versus standard monitoring and treatment as usual in premature infants - SafeBoosC
Region Hovestaden, Department of Neonatology 5024, Rigshospitalet0 sites11 target enrollmentTBD
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- cerebral hypoxia
- Sponsor
- Region Hovestaden, Department of Neonatology 5024, Rigshospitalet
- Enrollment
- 11
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
Trial is onging in other countries
Investigators
Eligibility Criteria
Inclusion Criteria
- •preterm, gestational age \<28 weeks, inborn, egiligible for inclusion within 3 hours after birth
Exclusion Criteria
- •congenital malformation, outborn, postnatal age more than 3 hours, no informed consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
utritional deficiencies in children with Attention Deficit/Hyperactivity Disorder: A focus on amino acidsAttention-deficit/hyperactivity disorderADHD10009841NL-OMON39106Ansynth Service B.V.187
Completed
N/A
Hemostasis in pediatric patients undergoing orthotopic liver transplantation: a prospective cohort study.NL-OMON45316niversitair Medisch Centrum Groningen50
Completed
N/A
Treatment of electroencephalographic status epilepticus after cardiopulmonary resuscitatioNL-OMON50403Ziekenhuis Rijnsate171
Completed
N/A
A First in Humans Study of Safety and Feasibility of baroloop: The baroloop Studyhypertension10057166NL-OMON54976neuroloop GmbH6
Completed
Phase 3
European Paediatric Soft Tissue Sarcoma Study Group RMS 2005 - a protocol for non metastatic rhabdomyosarcomaRhabdomyosarcomatumor of striated muscle10072990NL-OMON29994Academisch Medisch Centrum98